US Patent 9463170 Chemosensory receptor ligand-based therapies
Patent 9463170 was granted and assigned to Elcelyx Therapeutics Inc. on October, 2016 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9463170 Chemosensory receptor ligand-based therapies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
